These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 515872)

  • 1. Activation of uroporphyrinogen decarboxylase by ferrous iron in porphyria cutanea tarda.
    Blekkenhorst GH; Eales L; Pimstone NR
    S Afr Med J; 1979 Nov; 56(22):918-20. PubMed ID: 515872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
    Felsher BF; Carpio NM; Engleking DW; Nunn AT
    N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda.
    Elder GH; Lee GB; Tovey JA
    N Engl J Med; 1978 Aug; 299(6):274-8. PubMed ID: 661926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda.
    Mukerji SK; Pimstone NR; Burns M
    Gastroenterology; 1984 Dec; 87(6):1248-54. PubMed ID: 6489695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
    Kushner JP; Barbuto AJ; Lee GR
    J Clin Invest; 1976 Nov; 58(5):1089-97. PubMed ID: 993332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enzymatic defect in porphyria cutanea tarda.
    Kushner JP
    N Engl J Med; 1982 Apr; 306(13):799-800. PubMed ID: 7062954
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
    Kushner JP; Steinmuller DP; Lee GR
    J Clin Invest; 1975 Sep; 56(3):661-7. PubMed ID: 1159079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The enzymatic defects in porphyria cutanea tarda and variegate porphyria.
    Kushner JP
    Acta Derm Venereol Suppl (Stockh); 1982; 100():51-6. PubMed ID: 6962633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial porphyria cutanea tarda with normal erythrocytic urodecarboxylase: an exception to the rule?
    D'Alessandro Gandolfo L; Griso D; Macri A; Biolcati G; Topi GC
    Dermatologica; 1989; 178(4):206-8. PubMed ID: 2767288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies of the mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron under anaerobic conditions.
    Mukerji SK; Pimstone NR
    Arch Biochem Biophys; 1986 Feb; 244(2):619-29. PubMed ID: 3947082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients.
    Held JL; Sassa S; Kappas A; Harber LC
    J Invest Dermatol; 1989 Sep; 93(3):332-4. PubMed ID: 2768832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified human erythrocyte uroporphyrinogen decarboxylase and its amplification by iron.
    Mukerji SK; Pimstone NR; Tan KT
    FEBS Lett; 1985 Sep; 189(2):217-20. PubMed ID: 4043380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The porphyria cutanea tarda group: their role among the enzyme defects of heme biosynthesis].
    Adrien A; Guillet G
    Sem Hop; 1984 Apr; 60(16):1148-52. PubMed ID: 6326308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1988 Jul; 154(1):39-46. PubMed ID: 3395340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Porphyria cutanea tarda].
    Perrot H
    Ann Dermatol Venereol; 1987; 114(8):1023-6. PubMed ID: 3426071
    [No Abstract]   [Full Text] [Related]  

  • 16. [Decreased erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda].
    Kondo M
    Nihon Hifuka Gakkai Zasshi; 1985 Aug; 95(9):995-6. PubMed ID: 4079084
    [No Abstract]   [Full Text] [Related]  

  • 17. Modified uroporphyrinogen decarboxylase activity in a yeast mutant which mimics porphyria cutanea tarda.
    Rytka J; Bilinski T; Labbe-Bois R
    Biochem J; 1984 Mar; 218(2):405-13. PubMed ID: 6370240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.
    Elder GH; Sheppard DM; Tovey JA; Urquhart AJ
    Lancet; 1983 Jun; 1(8337):1301-4. PubMed ID: 6134095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.
    Elder GH; Urquhart AJ; De Salamanca RE; Munoz JJ; Bonkovsky HL
    Lancet; 1985 Aug; 2(8449):229-33. PubMed ID: 2862415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.
    Elder GH; Sheppard DM; De Salamanca RE; Olmos A
    Clin Sci (Lond); 1980 Jun; 58(6):477-84. PubMed ID: 7428280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.